Enliven Therapeutics (ELVN) Stock Chart & Stock Price History → Bill Clinton Backing Biden Replacement??? (From The Freeport Society) (Ad) Free ELVN Stock Alerts $22.57 +0.03 (+0.13%) (As of 05/31/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Enliven Therapeutics Stock Price Performance5 Day Performance-2.80%1 Month Performance+7.53%3 Month Performance+35.39%6 Month Performance+94.74%Year-To-Date Performance+63.08%1 Year Performance+4.73% Receive ELVN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Enliven Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad StocksToTradeWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made millionaire Tim Bohen is giving you an inside look at the megatrend that’s going to change everything.Discover the #1 company leading this revolution ELVN Stock Chart for Sunday, June, 2, 2024 ELVN Chart by TradingView Enliven Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/31/2024$22.54$22.57+0.13%$23.42$21.91285,962 shs$1.06 billion05/30/2024$21.33$22.54+5.67%$23.38$21.45157,297 shs$1.06 billion05/29/2024$23.22$21.33-8.14%$22.99$21.19138,486 shs$1.00 billion05/28/2024$23.94$23.22-3.01%$24.34$22.14221,804 shs$1.09 billion05/27/2024$23.94$23.94$24.13$22.73137,000 shs$1.13 billion05/24/2024$22.98$23.94+4.18%$24.13$22.73137,067 shs$1.13 billion Get the Latest News and Ratings for ELVN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Enliven Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 05/23/2024$22.89$22.98+0.39%$23.31$22.18296,352 shs$1.08 billion05/22/2024$22.90$22.89-0.04%$23.63$22.27216,177 shs$1.08 billion05/21/2024$24.00$22.90-4.58%$24.20$22.50696,228 shs$1.08 billion05/20/2024$23.04$24.00+4.17%$24.17$22.35583,394 shs$1.13 billion05/17/2024$23.81$23.04-3.23%$24.00$22.92392,489 shs$1.08 billion05/16/2024$24.00$23.81-0.79%$24.17$23.05388,823 shs$1.12 billion05/15/2024$23.87$24.00+0.54%$24.85$23.56395,853 shs$1.13 billion05/14/2024$24.49$23.87-2.53%$25.00$23.83342,706 shs$1.12 billion05/13/2024$23.43$24.49+4.52%$24.70$24.14196,214 shs$1.15 billion05/10/2024$23.90$23.43-1.97%$23.90$22.9998,397 shs$1.10 billion05/09/2024$24.49$23.90-2.41%$25.16$23.62425,778 shs$1.12 billion05/08/2024$24.70$24.49-0.85%$24.60$23.72432,449 shs$1.15 billion05/07/2024$22.92$24.70+7.77%$25.00$22.92608,889 shs$1.16 billion05/06/2024$22.65$22.92+1.19%$22.96$22.20307,122 shs$1.08 billion05/03/2024$20.99$22.65+7.91%$23.00$21.35482,543 shs$1.06 billion05/02/2024$18.10$20.99+15.97%$21.12$18.29221,412 shs$986.74 million05/01/2024$17.39$18.10+4.08%$18.76$17.68176,816 shs$850.88 million04/30/2024$17.79$17.39-2.25%$18.34$17.35792,794 shs$814.03 million04/29/2024$17.18$17.79+3.55%$18.79$17.41283,528 shs$832.75 million04/26/2024$16.78$17.18+2.38%$17.52$16.16148,934 shs$804.20 million04/25/2024$17.49$16.78-4.06%$17.36$16.53602,668 shs$785.47 million04/24/2024$17.37$17.49+0.69%$17.94$17.15221,584 shs$818.71 million04/23/2024$17.62$17.37-1.42%$18.20$17.01368,498 shs$813.09 million04/22/2024$17.28$17.62+1.97%$17.99$16.87280,702 shs$824.79 million04/19/2024$17.67$17.28-2.21%$18.51$15.96763,125 shs$808.88 million04/18/2024$17.30$17.67+2.14%$18.27$16.76211,501 shs$827.13 million04/17/2024$18.69$17.30-7.44%$19.45$17.09186,911 shs$712.76 million04/16/2024$19.94$18.69-6.27%$20.60$18.59147,810 shs$770.03 million04/15/2024$21.08$19.94-5.41%$21.19$19.55745,161 shs$821.53 million04/12/2024$23.82$21.08-11.50%$24.20$20.00853,372 shs$868.50 million04/11/2024$19.82$23.82+20.18%$26.00$22.623.35 million shs$981.38 million04/10/2024$19.19$19.82+3.28%$21.16$17.99832,208 shs$816.58 million04/09/2024$18.30$19.19+4.86%$19.97$18.27140,495 shs$790.63 million04/08/2024$19.40$18.30-5.67%$19.49$17.7087,392 shs$753.96 millionThe Only Energy Play You Should Be Looking At (Ad)Open AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has already inked deals with the Department of Energy.Click here to get all the information about it.04/05/2024$18.60$19.40+4.30%$19.65$18.17230,632 shs$799.28 million04/04/2024$18.59$18.60+0.05%$19.45$18.50184,850 shs$766.32 million04/03/2024$18.80$18.59-1.12%$19.00$18.04129,028 shs$765.91 million04/02/2024$18.90$18.80-0.53%$19.08$17.35383,056 shs$774.56 million04/01/2024$17.59$18.90+7.45%$19.36$17.32285,762 shs$778.68 million03/29/2024$17.59$17.59$18.69$17.36196,400 shs$724.71 million03/28/2024$18.63$17.59-5.58%$18.69$17.36196,384 shs$724.71 million03/27/2024$17.61$18.63+5.79%$18.81$17.5084,205 shs$767.56 million03/26/2024$17.78$17.61-0.96%$18.41$17.3497,388 shs$725.53 million03/25/2024$18.48$17.78-3.79%$18.89$16.81170,032 shs$732.54 million03/22/2024$18.06$18.48+2.33%$18.99$17.50137,240 shs$764.15 million03/21/2024$19.21$18.06-5.99%$19.20$17.59158,300 shs$746.78 million03/20/2024$17.54$19.21+9.52%$19.50$16.71252,538 shs$794.33 million03/19/2024$12.64$17.54+38.77%$18.15$14.50666,612 shs$725.28 million03/18/2024$11.97$12.64+5.60%$12.98$11.6774,346 shs$520.89 million03/15/2024$11.54$11.97+3.73%$12.26$11.02643,091 shs$493.28 million03/14/2024$12.27$11.54-5.95%$13.11$11.3596,076 shs$475.56 million03/13/2024$12.75$12.27-3.76%$12.83$12.2479,511 shs$505.65 million03/12/2024$13.48$12.75-5.42%$13.59$12.16221,118 shs$525.43 million03/11/2024$14.87$13.48-9.35%$14.69$13.4161,508 shs$555.51 million03/08/2024$15.40$14.87-3.44%$15.87$14.4746,231 shs$612.79 million03/07/2024$15.45$15.40-0.32%$16.11$15.2853,207 shs$634.63 million03/06/2024$16.04$15.45-3.68%$16.43$15.1942,263 shs$636.69 million03/05/2024$16.67$16.04-3.78%$16.41$15.8529,860 shs$661.01 million03/04/2024$16.67$16.67$17.10$15.7248,423 shs$686.97 million03/01/2024$15.97$16.67+4.38%$17.14$15.9655,164 shs$686.97 million Related Companies: Avadel Pharmaceuticals Stock Chart Editas Medicine Stock Chart Fulcrum Therapeutics Stock Chart Delcath Systems Stock Chart bluebird bio Stock Chart Lyra Therapeutics Stock Chart Orgenesis Stock Chart Intellia Therapeutics Stock Chart Alpine Immune Sciences Stock Chart Nuvalent Stock Chart Receive ELVN Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Enliven Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ELVN) was last updated on 6/2/2024 by MarketBeat.com Staff From Our PartnersBuy this small stock before coming AI Tidal WaveChaikin AnalyticsWrite this ticker symbol down…StocksToTradeTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProBill Clinton Backing Biden Replacement???The Freeport SocietyWarren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector…InvestorPlaceExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersHe Is Giving Away BitcoinCrypto Swap ProfitsShocking $16T Elon Musk Crypto LeakCrypto 101 Media Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Enliven Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.